2017
DOI: 10.3988/jcn.2017.13.3.310
|View full text |Cite|
|
Sign up to set email alerts
|

Severe Paraneoplastic Parkinsonism: A Rare Cause Revealing Breast Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
5
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 6 publications
0
5
0
Order By: Relevance
“…Positive immunofluorescence test results were also found after adding patient's anti-Hu on human myoenteric plexus commercial sections (image not shown). Notably, anti-NMDAR, GAD, CV2/CRMP5, and Ri antibodies, which have been previously reported to be associated with extrapyramidal syndromes (Tada et al, 2004 ; Pittock et al, 2006 ; Zandi et al, 2015 ; Mehta et al, 2016 ; Nabil et al, 2017 ), were absent.…”
Section: Case Presentationmentioning
confidence: 83%
See 1 more Smart Citation
“…Positive immunofluorescence test results were also found after adding patient's anti-Hu on human myoenteric plexus commercial sections (image not shown). Notably, anti-NMDAR, GAD, CV2/CRMP5, and Ri antibodies, which have been previously reported to be associated with extrapyramidal syndromes (Tada et al, 2004 ; Pittock et al, 2006 ; Zandi et al, 2015 ; Mehta et al, 2016 ; Nabil et al, 2017 ), were absent.…”
Section: Case Presentationmentioning
confidence: 83%
“…As regards to parkinsonism, the paraneoplastic form is a well-known, despite uncommon, entity whose first reports were described almost 30 years ago, with the finding of degeneration of substantia nigra in a patient with infiltrating ductal breast carcinoma (Golbe et al, 1989 ). Since then, several different autoantibodies have been associated to the development of clinically heterogeneous extrapyramidal syndromes, presenting with dystonia, dyskinesia, corea or other motor symptoms (Tada et al, 2004 ; Pittock et al, 2006 ; Zandi et al, 2015 ; Dash et al, 2016 ; Mehta et al, 2016 ; Nabil et al, 2017 ). However, to our knowledge, no clear evidence of causal relation between anti-Hu antibodies and parkinsonism has been reported so far.…”
Section: Discussionmentioning
confidence: 99%
“…Nabil et al also reported a 63-year-old woman with severe paraneoplastic parkinsonism who initially presented with gradual worsening of resting tremor for six months, action tremor, difficulty with walking, and unsteadiness for three months [ 10 ]. The resting tremor was asymmetric in the beginning but later became bilateral.…”
Section: Discussionmentioning
confidence: 99%
“…Rapidly worsening PSP have been reported in association with breast carcinoma and positive anti-Ri antibodies. [ 3 ] This patient had no functional imaging, did not respond to tumerectomy, immunotherapy, or levodopa, ultimately succumbing to her illness 8 months later. [ 3 ] B-cell lymphoma[ 4 ] and bronchial carcinoma[ 5 ] are the malignancies other than breast carcinoma though neither had any paraneoplastic antibody.…”
mentioning
confidence: 99%
“…[ 3 ] This patient had no functional imaging, did not respond to tumerectomy, immunotherapy, or levodopa, ultimately succumbing to her illness 8 months later. [ 3 ] B-cell lymphoma[ 4 ] and bronchial carcinoma[ 5 ] are the malignancies other than breast carcinoma though neither had any paraneoplastic antibody. Anti-Ri antibodies have been described in 2 patients with parkinsonism and breast cancer among 28 patients with paraneoplastic syndromes[ 6 ] making it the most commonly detected antibody in such a scenario and it has been associated with more severe neurological impairment.…”
mentioning
confidence: 99%